Skip to content
WeighLab
Provider review

Maves Review: Price, Pros & Cons

By The WeighLab Bench, Tools & Data Desk

Maves publishes compounded semaglutide at $249 monthly after a $189 first month and tirzepatide at $349 after a $249 first month, with clinician messaging and shipping included.

In this review

Compounded drugs are not FDA-approved. Treatment requires a clinician's assessment. Understand compounded GLP-1 treatment.

Check Maves prices Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.

Prices at a glance

Semaglutide
$249/moOngoing (compounded; first month $189)
Tirzepatide
$349/moOngoing (compounded; first month $249)
Coverage
Select U.S. states; list not published
Brand-name
Not confirmed

Semaglutide · estimated annual cost

$2,988

Tirzepatide · estimated annual cost

$4,188

Who Maves may suit

Readers comparing ongoing compounded GLP-1 prices who want named clinical leadership and will confirm state eligibility.

Where the value is

  • Publishes the introductory and ongoing price for each injectable medication
  • Names Dr. Michael Green as chief medical officer
  • Clinician review, dose adjustments, 24/7 messaging and shipping are included
  • The terms allow cancellation by account, email or phone

The tradeoffs

  • Availability varies by state and no treatment-specific state list is published
  • The dispensing pharmacies are not named
  • First-month discounts do not continue into later monthly bills
  • Paid membership fees and prescription products are non-refundable
  • Oral GLP-1 treatments are marked coming soon, and no branded GLP-1 plan is listed

How Maves prices its GLP-1s

Maves sells compounded semaglutide for $189 in the first month, then $249 monthly. Compounded tirzepatide costs $249 in the first month, then $349 monthly. The discounts are different: $60 off the first semaglutide month and $100 off the first tirzepatide month. Use the ongoing rate when comparing a longer course of care.

So budget with the regular monthly rate, not the first-month price. Maves describes its pricing as all-in: there's no membership fee, shipping is free, and the plan includes doctor-led care with 24/7 messaging. It doesn't take insurance, but HSA and FSA cards are eligible. You can cancel anytime.

Considering Maves?

Check the plan total, billing period and cancellation terms before you enroll. A clinician decides whether treatment is appropriate.

A men's health brand

Maves is pitched at men, and it frames weight loss as a "cut" phase within a broader fitness plan. It also markets bundles with sermorelin and NAD+, priced separately. Those marketing claims do not establish that adding a peptide will preserve muscle or improve weight-loss results. Discuss each proposed medication and its evidence with the prescriber. Your treatment may include vitamin B12 or other add-ons, depending on the formulation your clinician chooses. The same account sells sermorelin and NAD+ injections, priced separately.

Maves names Dr. Michael Green as chief medical officer and is operated by Homera Health. It isn't a pharmacy, and it doesn't name the licensed U.S. pharmacies that dispense its medication.

From questionnaire to delivery

You answer an online health questionnaire, and a licensed medical provider reviews it and, if appropriate, writes a personalized plan. Maves advertises same-day visits. Once prescribed, orders take two to three business days to process, with no shipping on weekends or holidays, and Homera Health's shipping policy puts average delivery at 4 to 12 business days. Tracking arrives by email once the order ships.

Prescription availability varies by state, so check yours in the questionnaire before you pay.

Returns and what to ask

Prescription products can't be returned, so every sale is final. If you think there's an error in how your prescription was filled, contact support right away. A package damaged in transit has to be claimed with the shipping carrier.

Its terms allow cancellation through your account, by email or by phone. Membership fees already paid are non-refundable. Confirm the deadline for stopping the next renewal and how that rule applies to an order approved but not yet shipped.

The Index scorecard

Maves scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month52/100
Price Transparency86/100
Nationwide Access24/100
Formulation Options66/100
Clinical Oversight88/100
Contract Flexibility49/100

The bottom line

Maves publishes compounded semaglutide at $249 monthly after a $189 first month and tirzepatide at $349 after a $249 first month, with clinician messaging and shipping included.

Compare the total cost of other GLP-1 programs and alternatives to Maves before deciding. A clinician should help you choose the right treatment.

Other programs to compare with Maves

These are partners: we may earn a commission if you sign up, at no cost to you.

  • FoundPartner

    Semaglutide modeled $215.58/mo · Tirzepatide modeled $313.08/mo

    Found bundles compounded semaglutide or tirzepatide into a care plan you can pay for with insurance or cash; month to month, semaglutide is $199 insured or $289 cash.

  • ShedRx (Shed)Partner

    Semaglutide modeled $199/mo · Tirzepatide modeled $299/mo

    Shed sells its GLP-1s as an injection, drops, lozenges or a daily pill, with brand-name Zepbound too; month to month, semaglutide is $199 and tirzepatide $299.

  • Strut HealthPartner

    Semaglutide modeled $99/mo · Tirzepatide modeled $149/mo

    Strut sells compounded semaglutide from $99 a month as a lozenge or $129 as a weekly injection, and tirzepatide from $149, all on auto-refill.

Compare with other providers

The providers whose Cost-Efficiency Index scores sit closest to Maves's. See the alternatives to Maves.

Explore more provider reviews

Pricing, states and verification reflect Maves's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Maves's site. Not medical advice; see our disclosure.

← Back to the value leaderboard